已核实 DOI PubMed 相关产品: 1

Phenylethanoid and Phenylmethanoid Glycosides from the Leaves of Ligustrum robustum and Their Bioactivities

Journal 2022 · IF 4.927 · 27(21): 7390 · 发表于 2022 年 10 月 31 日
作者: Shi-Hui Lu,Hao-Jiang Zuo,Jing Huang,Ran Chen,Jia-Ping Pan,Xiu-Xia Li
阅读全文 在 PubMed 查看

摘要

The phytochemical study on the leaves ofLigustrum robustum, which have been used as Ku-Ding-Cha, led to the isolation and identification of three new phenylethanoid glycosides and three new phenylmethanoid glycosides, named ligurobustosides R1(1b), R2–3(2), R4(3), S1(4b), S2(5), and S3(6), and five reported phenylethanoid glycosides (7–11). In the bioactivity test, (Z)-osmanthuside B6(11) displayed strong fatty acid synthase (FAS) inhibitory activity (IC50: 4.55 ± 0.35 μM) as the positive control orlistat (IC50: 4.46 ± 0.13 μM), while ligurobustosides R4(3) and S2(5), ligupurpuroside B (7),cis-ligupurpuroside B (8), ligurobustoside N (9), osmanthuside D (10), and (Z)-osmanthuside B6(11) showed stronger ABTS radical scavenging activity (IC50: 2.68 ± 0.05~4.86 ± 0.06 μM) than the positive control L-(+)-ascorbic acid (IC50: 10.06 ± 0.19 μM). This research provided a theoretical basis for the leaves ofL. robustumas a tea with function in treating obesity and diabetes.Keywords:Ligustrum robustum;phenylethanoid glycoside;phenylmethanoid glycosides;FAS;α-glucosidase;antioxidant;anti-obesity;hypoglycemic

本研究中使用的阿拉丁产品

1 款产品在本文中被引用